 |
|
|
| |
Long-Term Efficacy and Safety of E/C/F/TDF (STB) versus EFV/FTC/TDF (ATR) in HIV-1-Infected Treatment Naïve Black and Non-Black Subjects
|
| |
| |
Reported by Jules Levin
54th Interscience Conference on Antimicrobial
Agents and Chemotherapy
September 5-9, 2014 Washingtion DC, USA
WD Hardy1, J Gathe2, K Workowski3, J Stephens4, I Brar5, G Crofoot6, J DeMorin7, K Patel7, H Liu7, K White7, D McColl7, and J Szwarcberg7
1David Geffen School of Medicine, UCLA, Los Angeles, CA; 2Therapeutic Concepts, Houston, TX; 3Emory University, Atlanta, GA; 4Mercer School of Medicine, Atlanta, GA;
5Henry Ford Hospital, Detroit, MI; 6Gordon E. Crofoot, MD, Houston, TX; 7Gilead Sciences Inc., Foster City, CA
|
| |
|
|
|
|
|
